<DOC>
	<DOCNO>NCT03078543</DOCNO>
	<brief_summary>The ANTHEM™ Total Knee System conduct demonstrate non-inferiority 10 year implant survivorship patient undergoing total knee arthroplasty osteoarthritis compare report literature</brief_summary>
	<brief_title>Ten Year Implant Survivorship ANTHEM™ Total Knee System</brief_title>
	<detailed_description>The ANTHEM Study prospective , multicentre , cohort study collect relevant patient report , clinical , surgical radiological data 196 subject implant ANTHEM™ Knee System degenerative joint disease 6 clinical site globally . Total study duration study participant 10 year post-operative follow-up visit plan 6 week , 1 year , 2 year , 5 year , 7.5 year 10 year . The study evaluate 10 year implant survivorship safety outcome ANTHEM™ Knee System 10 year . This post-market study ANTHEM™ Total Knee System . The primary objective study demonstrate non-inferiority ( 5 % margin ) 10 year implant survivorship ANTHEM™ Total Knee System patient undergo total knee arthroplasty osteoarthritis compare report literature . The secondary objective study evaluate shorter long term safety outcomes ANTHEM™ Total Knee System . - Knee injury Osteoarthritis Outcomes Score ( KOOS ) - 2011 Knee Society Score ( 2011 KSS ) - EQ-5D - 3L - Femoral Fit ( 'Perfect Fit ' rate ) - Radiographic Assessment - Revision reason - Adverse Events ( AEs )</detailed_description>
	<criteria>1 . Subject candidate primary total knee arthroplasty due degenerative joint disease 2 . Subject willing sign date ECapproved consent form 3 . Subject male female age 18 75 year age 4 . Subject plan available ten ( 10 ) year postoperative followup 5 . Subject agree follow study protocol 1 . Subject would receive ANTHEM™ Total Knee System affect knee revision previously fail total unicondylar knee arthroplasty 2 . Subject receive TKA contralateral knee revision previously fail total unicondylar knee arthroplasty 3 . Subject history patellar fracture , patellectomy , patellofemoral instability 4 . Subject inflammatory arthritis 5 . Subject possess contralateral ipsilateral revision hip arthroplasty 6 . Subject ipsilateral hip arthritis result flexion contracture 7 . Subject one follow arthroplasty fully heal wellfunctioning , determine Investigator : Ipsilateral contralateral primary total hip arthroplasty hip resurface arthroplasty Contralateral primary total knee unicondylar knee arthroplasty 8 . Subject active infection sepsis ( treat untreated ) 9 . Subject presence malignant tumor , either primary metastatic , benign tumor leg knee treat 10 . Subject condition may interfere TKA survival outcome ( e.g . Paget 's Charcot 's disease , vascular insufficiency , muscular atrophy , uncontrolled diabetes mellitus i.e . treatment oral/injectable medication control blood glucose level , fibromyalgia , moderate severe renal insufficiency neuromuscular disease ) 11 . Subject contralateral low extremity condition cause abnormal ambulation ( e.g . ankle fusion , ankle arthroplasty , previous hip fracture ) 12 . Subject pregnant plan become pregnant study 13 . Subject emotional neurological condition would preempt ability willingness participate study , include mental illness , mental retardation , drug alcohol abuse 14 . Subject BMI &gt; 40 15 . Subject enrol another investigational drug , biologic , device study 16 . Subject face current impending incarceration 17 . Subject inadequate bone stock support device would make procedure unjustifiable , include limited : severe osteopenia/osteoporosis family history severe osteoporosis/osteopenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>